Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sammy Weiser Novak

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Dark Microglia Are Abundant in Normal Postnatal Development, where they Remodel Synapses via Phagocytosis and Trogocytosis, and Are Dependent on TREM2Haley A Vecchiarelli, Kanchan Bisht, Kaushik Sharma, et al.
Gastroenterology|July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2025
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potentialJeremy R Tuck, Lee E Dunlap, Yara A Khatib, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Dark Microglia Are Abundant in Normal Postnatal Development, where they Remodel Synapses via Phagocytosis and Trogocytosis, and Are Dependent on TREM2Haley A Vecchiarelli, Kanchan Bisht, Kaushik Sharma, et al.
Gastroenterology|July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2025
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potentialJeremy R Tuck, Lee E Dunlap, Yara A Khatib, et al.
Pageof 3